Elevation Oncology, INC Form 4 insider transactions

Director Julie Cherrington acquired 35,000 stock options in Elevation Oncology, Inc. on June 13, 2024.

R Michael Carruthers, a director at Elevation Oncology, acquired 35,000 stock options on June 13, 2024, according to a recent SEC filing.

Tammy Furlong, CFO of Elevation Oncology, reports the vesting and subsequent disposal of shares related to restricted stock units.

Elevation Oncology's CEO, Joseph Ferra Jr., reported the disposition of shares to cover tax obligations upon the vesting of restricted stock units.

Director Alan B. Sandler acquired 55,000 stock options in Elevation Oncology, Inc. on February 29, 2024, according to a Form 4 filing.

Julie M Cherrington, a director at Elevation Oncology, was granted stock options for 55,000 shares of common stock on February 29, 2024.